Jonathan Licht
University of Florida
H-index: 89
North America-United States
Top articles of Jonathan Licht
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
KDM6A Regulates Immune Response Genes in Multiple Myeloma | bioRxiv | Daphne Dupéré-Richer Alberto Riva Sayantan Maji Benjamin Gabriel Barwick Heidi Casella | 2024 |
NSD2 overexpression drives multiple myeloma dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome | Cancer Research | Amin Sobh Elena Encinas Alisha Patel Greeshma Surapaneni Charlotte Kaestner | 2024/3/22 |
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells | bioRxiv | Corynn Kasap Adila Izgutdina Bonell Patiño-Escobar Amrik Kang Nikhil Chilakapati | 2024 |
Enhancer of zeste homolog 2 inhibitors overcome glucocorticoid resistance in acute lymphoblastic leukemia by augmenting pro-apoptotic signaling | Cancer Research | Mansi Dalal Joanna Yi Jianping Li Amin Shobh Daphne DupereRicher | 2024/3/22 |
NSD2 drives t (4; 14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome | Blood Journal | Amin Sobh Elena Encinas Alisha M Patel Greeshma Surapaneni Emilie Bonilla | 2024/4/10 |
HDAC8 regulates immune escape in melanoma through increased transcription of inhibitory cytokines that increase accumulation of myeloid-derived suppressor cells (MDSCs) | Cancer Research | Chao Zhang Michael Emmons Richard Bennett Jonathan Licht Keiran Smalley | 2023/4/4 |
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias | Nature Cancer | Ricardo de Matos Simoes Ryosuke Shirasaki Sondra L Downey-Kopyscinski Geoffrey M Matthews Benjamin G Barwick | 2023/5 |
Recruitment of FBXO22 for Targeted Degradation of NSD2 | bioRxiv | David Y Nie John R Tabor Jianping Li Maria Kutera Jonathan St-Germain | 2023/11/2 |
Low muscle mass is associated with a higher risk of all–cause and cardiovascular disease–specific mortality in cancer survivors | Nutrition | Dongyu Zhang Kori A Spiropoulos Akemi Wijayabahu Demetra D Christou Shama D Karanth | 2023/3/1 |
Identifying molecular targets to overcome CNS infiltration in acute lymphoblastic leukemia associated with an activating mutation of the NSD2 histone methyltransferase | Cancer Research | Charlotte L Kaestner Amin Sobh Jianping Li Katelyn Raburn Alberto Riva | 2023/4/4 |
To define how the uvel melanoma-liver environment crosstalk shapes metastasis growth and therapeutic response | Cancer Research | Sathya Neelature Sriramareddy Zhihua Chen Jiannong Li Ann Chen Jonathan D Licht | 2023/4/4 |
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck | Cell reports | Nupur Nigam Benjamin Bernard Samantha Sevilla Sohyoung Kim Mohd Saleem Dar | 2023/7/25 |
Histone mutations in cancer | Kimberly N Espinoza Pereira Jixiu Shan Jonathan D Licht Richard L Bennett | 2023/10/31 | |
Activating NSD2 Mutations Drive Oncogenic Reprogramming By Disturbing Epigenetic Landscape in Mantle Cell Lymphoma | Blood | Jianping Li Marta Kulis Alberto Riva Heidi Casellas Román Daphne Dupere-Richer | 2023/11/28 |
Piperlongumine conjugates induce targeted protein degradation | Cell Chemical Biology | Jing Pei Yufeng Xiao Xingui Liu Wanyi Hu Amin Sobh | 2023/2/16 |
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis | Nature communications | Michael F Emmons Richard L Bennett Alberto Riva Kanchan Gupta Larissa Anastasio Da Costa Carvalho | 2023/11/29 |
Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States | Cancer Medicine | Yi Guo Jiang Bian Zhaoyi Chen Jennifer N Fishe Dongyu Zhang | 2023/5 |
HIRA-mediated loading of histone variant H3. 3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers | Nucleic Acids Research | Viacheslav M Morozov Alberto Riva Sadia Sarwar Wan-Ju Kim Jianping Li | 2023/10/27 |
Natural Killer Cells Are Active Against Myeloma, Leukemia or Lymphoma Cells with Loss of Tumor Suppressor Genes | Blood | Olga Dashevsky Sara Gandolfi Olli Dufva Ricardo De Matos Simoes Jani Huuhtanen | 2023/11/28 |
Abstract B001: Elevated all-cause and cardiovascular mortality in cancer survivors with sarcopenia | Cancer Research | Dejana Braithwaite Shama Karanth Christiaan Leeuwenburgh Todd M Manini Meghann Wheeler | 2023/1/15 |